Skip to main content
. Author manuscript; available in PMC: 2019 Aug 6.
Published in final edited form as: Eur Urol. 2017 Sep 28;73(1):62–68. doi: 10.1016/j.eururo.2017.09.008

Fig. 2 –

Fig. 2 –

Disease-Free survival in patients at higher risk according to blinded independent central review. Higher risk was defined as T3, no or undetermined nodal involvement, no metastasis, Fuhrman grade ≥2, ECOG PS ≥1; or T4 and/or nodal involvement. CI = confidence interval; HR = hazard ratio; DFS = disease-free survival; NR = not reached.